Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06197152
What this trial is testing

Identification and Clinical Validation of Biomarkers Associated With Clinical Severity in Adults Infected With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Assistance Publique - Hôpitaux de Paris 133
Not applicableStudy completedNCT06185647
What this trial is testing

Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)Immunization; Infection
Hôpital Armand Trousseau 4,924
Not applicableActive Not RecruitingNCT05443607
What this trial is testing

Transplacental Transmission of RSV (TTRSV)

Who this might be right for
SARS CoV 2 InfectionRespiratory Syncytial Virus (RSV)Bronchiolitis+1 more
Tulane University 300
Early research (Phase 1)Study completedNCT03102034
What this trial is testing

Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Early research (Phase 1)Study completedNCT04090658
What this trial is testing

Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 40
Testing effectiveness (Phase 2)Looking for participantsNCT07762014
What this trial is testing

RBCG-N-RSV Vaccine in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infection PreventionTuberculosis Prevention
Biothervax SpA 200
Large-scale testing (Phase 3)Ended earlyNCT04980391
What this trial is testing

A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 384
Not applicableNot Yet RecruitingNCT07346963
What this trial is testing

RSV-Positive Children <5 Years Presenting to Pediatric Emergency Departments in Türkiye: TRUST-RSV

Who this might be right for
Respiratory Syncytial Virus InfectionAcute Bronchiolitis Due to Respiratory Syncytial VirusPneumonia+1 more
Eskisehir Osmangazi University 4,000
Testing effectiveness (Phase 2)Study completedNCT00232635
What this trial is testing

The Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT

Who this might be right for
Respiratory Syncytial Virus Infections
Arrow Therapeutics 27
Not applicableStudy completedNCT03728413
What this trial is testing

The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus

Who this might be right for
RSV Infection
Imperial College London 28
Not applicableStudy completedNCT01249625
What this trial is testing

The Respiratory Protection Effectiveness Clinical Trial

Who this might be right for
InfluenzaRespiratory Syncytial VirusesParamyxoviridae Infections+2 more
Johns Hopkins University 2,862
Not applicableActive Not RecruitingNCT07264478
What this trial is testing

Diagnosis and Treatment Status and Medical Burden of Respiratory Syncytial Virus Infection in Children in China

Who this might be right for
RSV InfectionDisease Burden
Beijing Children's Hospital 1,100
Not applicableStudy completedNCT00111878
What this trial is testing

Study to Evaluate MEDI-534 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsParainfluenza Infections
MedImmune LLC 120
Large-scale testing (Phase 3)Study completedNCT02911935
What this trial is testing

Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II

Who this might be right for
Respiratory Syncytial Virus, Bronchiolitis
Washington University School of Medicine 200
Not applicableUnknownNCT02093715
What this trial is testing

FeNO and Cytokines in Respiratory Syncytial Virus (RSV) and Non RSV Bronchiolitis in Relation to Future Asthma

Who this might be right for
Acute Bronchiolitis
Tel-Aviv Sourasky Medical Center 400
Large-scale testing (Phase 3)Study completedNCT01006629
What this trial is testing

Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children

Who this might be right for
Respiratory Syncytial Virus InfectionPremature BirthBronchopulmonary Dysplasia+1 more
Abbott 100
Not applicableUnknownNCT05928507
What this trial is testing

FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol

Who this might be right for
Influenza AInfluenza Type BSARS CoV 2 Infection+1 more
Baebies, Inc. 2,500
Testing effectiveness (Phase 2)Looking for participantsNCT07214571
What this trial is testing

S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

Who this might be right for
Respiratory Syncytial Virus Infections
Shionogi 192
Large-scale testing (Phase 3)Study completedNCT05301322
What this trial is testing

Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age

Who this might be right for
Respiratory Syncytial Virus
Pfizer 1,471
Early research (Phase 1)Study completedNCT04851977
What this trial is testing

A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. 60
Next Page